Directory
>
Rachel Haurwitz
Rachel Haurwitz
President and CEO | Caribou Biosciences
United States
Rachel Haurwitz
Summary
Rachel Haurwitz is the CEO of Caribou Biosciences, Inc., a leading company in the field of biotechnology. With a PhD in Molecular and Cell Biology from the University of California, Berkeley, she has a strong academic foundation that complements her extensive experience in the life sciences sector. Haurwitz has been recognized as one of the most influential women in business and has received numerous accolades, including being featured in Forbes' 30 Under 30 list. Her expertise spans various disciplines such as biochemistry, genetics, and protein chemistry, making her a prominent figure in the biotech industry. As a board member at Seer and a former director at Intellia Therapeutics, she has a wealth of leadership experience. Haurwitz is not only a scientist but also a trailblazer in applying innovative technologies to advance healthcare solutions, showcasing her commitment to driving change in the industry.
Rachel Haurwitz
Work Experience
President and CEO at
Caribou Biosciences
August 2012 - Present
Board Member at
Seer
November 2021 - July 2024
Member of the Board of Directors at
Intellia Therapeutics, Inc.
January 2014 - November 2016
Rachel Haurwitz
Education
Harvard college, Ab
Frequently Asked Questions about Rachel Haurwitz
What is Rachel Haurwitz email address?
Rachel Haurwitz's primary email address is ********@cariboubio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Rachel Haurwitz work for?
Rachel Haurwitz is a President and CEO at Caribou Biosciences, a company specializing in Commercial physical research.
Where Rachel Haurwitz graduated from?
Rachel Haurwitz holds a degree in Molecular And Cell Biology from University of California, Berkeley.
How can I directly contact Rachel Haurwitz?
To contact Rachel Haurwitz directly, you can use the email address ********@cariboubio.com. Complete contact information is available upon registration with Muraena.
Who is Rachel Haurwitz?
Rachel Haurwitz is the CEO of Caribou Biosciences, Inc., a leading company in the field of biotechnology. With a PhD in Molecular and Cell Biology from the University of California, Berkeley, she has a strong academic foundation that complements her extensive experience in the life sciences sector. Haurwitz has been recognized as one of the most influential women in business and has received numerous accolades, including being featured in Forbes' 30 Under 30 list. Her expertise spans various disciplines such as biochemistry, genetics, and protein chemistry, making her a prominent figure in the biotech industry. As a board member at Seer and a former director at Intellia Therapeutics, she has a wealth of leadership experience. Haurwitz is not only a scientist but also a trailblazer in applying innovative technologies to advance healthcare solutions, showcasing her commitment to driving change in the industry.
Rachel`s contact details
********@cariboubio.com
***************@intelliatx.com
*********@seer.bio
Colleagues
VP of Finance and Controller
Vice President Program Management - Therapeutics Product Development
Vice President of Operations and Information Technology
Chief People Officer
Board Member
Executive Director, Stem Cell Therapeutics
Board Member
Board Member
VP of Platform Research
Vice President of Technical Operations